What is the latest news on CYTK? | Glauxie AI

Q: What is the latest news on CYTK?

18 news articles for CYTK in the past 30 days. Latest: "Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)". 4 SEC Form 8-K filings in the past 90 days.

Q: What happened to CYTK today?

Get a recap of what happened to CYTK stock today — price move, catalysts, and key events.

Q: Why is CYTK going up today?

Find out why CYTK stock is up today with real-time data, news catalysts, and move analysis.

Q: Why is CYTK down today?

Find out why CYTK stock is down today with real-time data, news catalysts, and move analysis.

What is the latest news on CYTK?

🦉

Latest News & Events — CYTK

18 articles in the past 30 days

Cytokinetics to Host Annual Symposium on Contemporary Landscapes in Muscle Biology (CLIMB)
Benzinga-Biotech ·

Cytokinetics Announces New Data Related to MYQORZO® (aficamten) at ESC Heart Failure 2026
GlobeNewsWire-FDA ·

Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $805 Million
Benzinga-News ·

Cytokinetics prices upsized $700M equity raise at $71 per share
SeekingAlpha ·

CYTK Q1 Earnings Match Estimates, Revenues Beat on Myqorzo Launch
Zacks ·

Cytokinetics outlines $830M-$870M 2026 operating expense range while advancing MYQORZO Germany launch
SeekingAlpha ·

Cytokinetics (CYTK) Reports Q1 Loss, Beats Revenue Estimates
Zacks ·

SEC Form 8-K Filings (4 in 90 days)

—

CYTK News CYTK Overview

What happened to CYTK today? Why is CYTK going up today? Why is CYTK down today?

Latest News & Events — CYTK

Top Stories

SEC Form 8-K Filings (4 in 90 days)

Sign in to InsiderStreet